Your browser doesn't support javascript.
loading
Outcomes of Patients With Premature Discontinuation of the 21-h Intravenous N-Acetylcysteine Protocol After Acute Acetaminophen Overdose.
Lucyk, Scott N; Yarema, Mark C; Sivilotti, Marco L A; Johnson, David W; Nettel-Aguirre, Alberto; Victorino, Charlemaigne; Bailey, Benoit; Dart, Richard C; Heard, Kennon; Spyker, Daniel A; Rumack, Barry H.
Afiliação
  • Lucyk SN; Department of Emergency Medicine, University of Alberta, Edmonton, Alberta, Canada; Ronald O. Perelman Department of Emergency Medicine, New York University School of Medicine, New York, New York; Poison and Drug Information Service, Alberta Health Services, Calgary, Alberta, Canada; Department of E
  • Yarema MC; Department of Emergency Medicine, University of Alberta, Edmonton, Alberta, Canada; Poison and Drug Information Service, Alberta Health Services, Calgary, Alberta, Canada; Department of Emergency Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Physiology and Pharmacology, Un
  • Sivilotti ML; Departments of Emergency Medicine, and of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada; Ontario Poison Centre, Toronto, Ontario, Canada.
  • Johnson DW; Poison and Drug Information Service, Alberta Health Services, Calgary, Alberta, Canada; Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
  • Nettel-Aguirre A; Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute for Child & Maternal Health, Calgary, Alberta, Canada.
  • Victorino C; Statistics Canada, Microdata Access Division, Prairie Regional Research Data Centre, University of Calgary, MLT-116, 2500 University Dr. NW, Calgary, Alberta, Canada.
  • Bailey B; Division of Emergency Medicine, CHU Sainte Justine, Montreal, Quebec, Canada.
  • Dart RC; Rocky Mountain Poison and Drug Center, Denver Hospital Health Authority, Denver, Colorado.
  • Heard K; Rocky Mountain Poison and Drug Center, Denver Hospital Health Authority, Denver, Colorado.
  • Spyker DA; Department of Emergency Medicine, Oregon Poison Center, Oregon Health & Science University, Portland, Oregon.
  • Rumack BH; Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado.
J Emerg Med ; 50(4): 629-37, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26899513
ABSTRACT

BACKGROUND:

The minimum recommended treatment duration for i.v. N-acetylcysteine (NAC) after an acute, single acetaminophen (APAP) overdose is 21 h. Some have questioned whether shorter courses may be sufficient in carefully selected cases.

OBJECTIVE:

We sought to describe the incidence of hepatotoxicity in a cohort of acute APAP overdose patients who received <21 h of i.v. NAC for any reason.

METHODS:

We performed a secondary analysis of a large multicenter retrospective cohort of patients hospitalized for APAP poisoning. We selected patients with a potentially toxic serum APAP concentration measured between 4 and 24 h post ingestion, in whom i.v. NAC was initiated but discontinued before completing the full 21-h course. We further characterized outcomes in these patients as a function of two novel risk-prediction tools, the psi (ψ) parameter and APAP × aminotransferase (AT) product. The ψ parameter is an estimate of the cellular burden of injury based on the area under the concentration-time curve before treatment, and calculated with respect to the APAP concentration and time to initiation of NAC.

RESULTS:

Fifty-nine patients met inclusion criteria. Intravenous NAC was initiated a median of 11.3 h post ingestion and administered for a median of 11.0 h. Hepatotoxicity (aspartate aminotransferase [AST] or alanine aminotransferase [ALT] > 1,000 IU/L) occurred in one patient (1.7%; 95% confidence interval 0.04-9.1), and eight additional patients developed hepatic injury (AST or ALT > 100 IU/L). No fatalities occurred. A multiplication product of APAP and AT (APAP × AT) that falls below 10,000 µmol/L/IU-L, or pretreatment ψ < 5 mmol/L-h suggested a low risk of hepatic injury.

CONCLUSIONS:

In this retrospective analysis of patients treated with < 21 h of i.v. NAC for acute APAP overdose, the incidence of hepatotoxicity and coagulopathy was low, despite delays to NAC treatment.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acetilcisteína / Acetaminofen Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acetilcisteína / Acetaminofen Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article